Panel of serum metabolites discriminates cancer patients and healthy participants of lung cancer screening - A pilot study

Acta Biochimica Polonica

Volumn 64, Issue 3, 2017, Pages 513-518

  Roś Mazurczyk, Małgorzata ^a   Wojakowska, Anna ^a   Marczak, Łukasz ^b   Polański, Krzysztof ^c   Pietrowska, Monika ^a   Polanska, Joanna ^d   Dziadziuszko, Rafał ^e   Jassem, Jacek ^e   Rzyman, Witold ^e   Widlak, Piotr ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^e MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Early detection; Lung cancer screening; Metabolomics; Serum biomarkers

Indexed keywords

TUMOR MARKER;

AGED; BLOOD; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LUNG TUMOR; MALE; MASS FRAGMENTOGRAPHY; METABOLOME; MIDDLE AGED; NORMAL HUMAN; PILOT STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; X-RAY COMPUTED TOMOGRAPHY;

AGED; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEALTHY VOLUNTEERS; HUMANS; LUNG NEOPLASMS; MALE; METABOLOME; MIDDLE AGED; PILOT PROJECTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85029559478     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2017_1517     Document Type: Article

References (29)

1. Aberle DR, Adams AM, Berg CD, et al. (2011) National lung screening trial research team reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365: 395-409. http://doi: 10.1056/NEJMoa1102873
2. Bajtarevic A, Ager C, Pienz M, Klieber M, Schwarz K, Ligor M, Ligor T, Filipiak W, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Haidenberger A, Buszewski B, Miekisch W, Schubert J, Amann A (2009) Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 9: 348. http://doi: 10.1186/1471-2407-9-348
3. Chen Y, Ma Z, Min L, Li H, Wang B, Zhong J, Dail L (2015) Biomarker identification and pathway analysis by serum metabolomics of lung cancer. Biomed Res Int 2015: 183624. http://doi: 10.1155/2015/183624
4. Comstock GW, Alberg AJ, Huang HY, Wu K, Burke AE, Hoffman SC, Norkus EP, Gross M, Cutler RG, Morris JS, Spate VL, Helzlsouer KJ (2008) The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acids, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. Am J Epidemiol 168: 831-840. http://doi: 10.1093/aje/kwn328
5. Deja S, Porebska I, Kowal A, Zabek A, Barg W, Pawelczyk K, Stanimirova I, Daszykowski M, Korzeniewska A, Jankowska R, Mlynarz P (2014) Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease. J Pharm Biomed Anal 100: 369-380. http://doi: 10.1016/j. jpba.2014.08.020
6. Guo Y, Wang X, Qiu L, Qin X, Liu H, Wang Y, Li F, Wang X, Chen G, Song G, Li F, Guo S, Li Z (2012) Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry. Clin Chim Acta 414: 135-141. http://doi: 10.1016/j.cca.2012.08.010
7. Hassanein M, Callison JC, Callaway-Lane C, Aldrich MC, Grogan EL, Massion PP (2012) The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) 5: 992-1006. http:// doi: 10.1158/1940-6207.CAPR-11-0441
8. Hassanein M, Rahman JS, Chaurand P, Massion PP (2011) Advances in proteomic strategies toward the early detection of lung cancer. Proc Am Thorac Soc 8: 183-188. http://doi: 10.1513/pats.201012-069MS
9. Hoffman PC, Mauer AM, Vokes EE (2000) Lung cancer. Lancet 355: 479-485. http://doi:10.1016/S0140-6736(00)82038-3
10. Hori S, Nishiumi S, Kobayashi K, Shinohara M, Hatakeyama Y, Kotani Y, Hatano N, Maniwa Y, Nishio W, Bamba T, Fukusaki E, Azuma T, Takenawa T, Nishimura Y, Yoshida M (2011) A metabolomic approach to lung cancer. Lung Cancer 74: 284-292. http://doi: 10.1016/j.lungcan.2011.02.008
11. Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19: 1893-1907. http://doi: 10.1158/1055-9965.EPI-10-0437
12. Jordan KW, Adkins CB, Su L, Halpern EF, Mark EJ, Christiani DC, Cheng LL (2010) Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissueserum pairs, Lung Cancer 68: 44-50. http://doi: 10.1016/j.lungcan. 2009.05.012
13. Liu J, Mazzone PJ, Cata JP, Kurz A, Bauer M, Mascha EJ, Sessler DI (2014) Serum free fatty acid biomarkers of lung cancer. Chest 146: 670-679. http://doi: 10.1378/chest.13-2568
14. Louis E, Adriaensens P, Guedens W, Bigirumurame T, Baeten K, Vanhove K, Vandeurzen K, Darquennes K, Vansteenkiste J, Dooms C, Shkedy Z, Mesotten L, Thomeer M (2016) Detection of lung cancer through metabolic changes measured in blood plasma. J Thor Oncol 11: 516-523. http://doi: 10.1016/j.jtho.2016.01.011
15. Mahabir S, Schendel K, Dong YQ, Barrera SL, Spitz MR, Forman MR (2008) Dietary alpha-, beta-, gamma-and delta-tocopherols in lung cancer risk. Int J Cancer 123: 1173-1180. http://doi: 10.1002/ ijc.23649
16. Mazzone PJ, Wang XF, Beukemann M, Zhang Q, Seeley M, Mohney R, Holt T, Pappan KL (2016) Metabolite profiles of the serum of patients with non-small cell carcinoma. J Thor Oncol 11: 72-88. http://doi: 10.1016/j.jtho.2015.09.002
17. Priola AM, Priola SM, Giaj-Levra M, Basso E, Veltri A, Fava C, Cardinale L. (2013) Clinical implications and added costs of incidental findings in an early detection study of lung cancer by using lowdose spiral computed tomography. Clin Lung Cancer 14: 139-148. http://doi: 10.1016/j.cllc.2012.05.005
18. Puchades-Carrasco L, Jantus-Lewintre E, Pérez-Rambla C, García-García F, Lucas R, Calabuig S, Blasco A, Dopazo J, Camps C, Pineda-Lucena A (2016) Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer. Oncotarget 7: 12904-12916. http://doi: 10.18632/oncotarget.7354
19. Rocha CM, Carrola J, Barros AS, Gil AM, Goodfellow BJ, Carreira IM, Bernardo J, Gomes A, Sousa V, Carvalho L, Duarte IF (2011) Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasma. J Proteome Res 10: 4314-4324. http:// doi: 10.1021/pr200550p
20. Rzyman W, Dziedzic R, Jelitto-Górska M, Biadacz I, Ksiazek J, Siebert J, Zdrojewski T, Studniarek M (2015) Results of an open-access lung cancer screening program with low-dose computed tomography: the Gdansk experience. Pol Arch Med Wewn 125: 232-239
21. Rzyman W, Jelitto-Gorska M, Dziedzic R, Biadacz I, Ksiazek J, Chwirot P, Marjanski T (2013) Diagnostic work-up and surgery in participants of the Gdansk lung cancer screening programme: the incidence of surgery for non-malignant conditions. Interact Cardiovasc Thorac Surg 17: 969-973. http://doi: 10.1093/icvts/ivt388
22. Sozzi G, Boeri M (2014) Potential biomarkers for lung cancer screening. Transl Lung Cancer Res 3: 139-1348. http://doi: 10.3978/j. issn.2218-6751.2014.06.04
23. Spratlin JL, Serkova NJ, Eckhardt SG (2009) Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15: 431-440. http://doi: 10.1158/1078-0432.CCR-08-1059
24. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics 2012. CA Cancer J Clin 65: 87-108. http://doi: 10.3322/caac.21262
25. Virtamo J, Taylor PR, Kontto J, Männistö S, Utriainen M, Weinstein SJ, Huttunen J, Albanes D (2014) Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Int J Cancer 135: 178-185. http://doi: 10.1002/ijc.28641
26. Wang L, Tang Y, Liu S, Mao S, Ling Y, Liu D, He X, Wang X (2013) Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals. PloS One 8: e65675. http://doi: 10.1371/journal.pone.0065675
27. Willett WC, Polk BF, Underwood BA, Stampfer MJ, Pressel S, Rosner B, Taylor JO, Schneider K, Hames CG. (1984) Relation of serum vitamins A and E and carotenoids to the risk of cancer. N Engl J Med 310: 430-434
28. Wright GS, Gruidl ME (2000) Early detection and prevention of lung cancer. Curr Opin Oncol 12: 143-148
29. Wu QJ, Xiang YB, Yang G, Li HL, Lan Q, Gao YT, Zheng W, Shu XO, Fowke JH (2015) Vitamin E intake and the lung cancer risk among female nonsmokers: a report from the Shanghai Women's Health Study. Int J Cancer 136: 610-617. http://doi: 10.1002/ ijc.29016